Arasila Biotech is categorized under Computer Software Development and Applications in San Diego, CA and active since 2012.
Arasila Biotech was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Computer Software Development and Applications business, which does work in the BOTH market, and is classified as a Computer Software Development and Applications, under code number 541511 by the NAICS.
If you are seeking more information, feel free to contact Sara Zarei at the company’s single location by writing to 4289 Calle Isabelino, San Diego, California CA 92130 or by phoning (760) 845-0956. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Arasila Biotech |
| Contact Person: | Sara Zarei |
| Address: | 4289 Calle Isabelino, San Diego, California 92130 |
| Phone Number: | (760) 845-0956 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Computer Software Development and Applications |
| SIC Code: | 7371 |
| NAICS Code: | 541511 |
| Share This Business: |
Arasila Biotech was started in 2012 to provide professional Computer Software Development and Applications under the SIC code 7371 and NAICS code 541511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Sara Zarei for inquiries that concern Arasila Biotech by calling the company number (760) 845-0956, as your correspondence is most welcome. Additionally, the physical location of the single location of Arasila Biotech can be found at the coordinates 32.920831,-117.222086 as well as the street address 4289 Calle Isabelino in San Diego, California 92130.
For its online presence, you may visit Arasila Biotech’s website at and engage with its social media outlets through on Twitter and on Facebook.